Our work with technical experts, key opinion leaders and governments has provided us a unique position to share best practices around COVID-19 testing and contribute to recommendations.
COVID-19 Think Tank for Lateral Flow Assay (LFA) Testing Strategies
As a response to the urgent need for increased testing capacity, particularly in resource-constrained countries, GHIG facilitated a Think Tank of global key opinion leaders and experts in diagnostics and COVID-19 to gather knowledge on best practices around testing strategies. This work was presented to the global COVID community of scientists, clinicians, healthcare and laboratory professionals through a series of regional webinars and resulted in a publication in Lancet.
The WHO recently announced an agreement with Africa CDC, FIND, Unitaid and other partners to make 120 million SARS-CoV-2 antigen RDTs available to low- and middle-income countries (LMICs). GHIG will re-convene the Think Tank to review COVID-19 testing situations across the regions and discuss testing strategies to include antigen RDTs to provide safe work and school environments and allow for travel across borders.
Serology testing in the COVID-19 pandemic response —
COVID-19 Diagnostics and Serology Testing Regional Webinars
The COVID-19 Think Tank recommendations on testing strategies were shared openly through a series of regional webinars to also allow for input from countries. More than 1,200 people from greater than 85 countries participated in the webinars held for the Africa, Asia Pacific, Latin America and Middle East regions. Webinars were in English, Spanish and Portuguese and are archived on our Global Health CPD YouTube channel.
GHCPD YouTube Channel
We have collated frequently asked questions (FAQs) from the webinars – coming soon.
To prepare for projects, GHIG conducts literature and systematic reviews. We also conduct interviews with key stakeholders, country representatives from the Ministry of Health, implementing partners and industry to collect anecdotal evidence and best practices.
We will soon be publishing a scoping review of the literature on the use of serology tests for COVID-19. For immediate information, feel free to contact us at email@example.com.